Marketdash
Back to News

Autodesk Gets a Bullish Call: 5 Analyst Upgrades Making Waves

MarketDash Editorial Team
11 days ago
Wall Street analysts are shifting their stance on several notable companies, with Autodesk leading the pack as Deutsche Bank flips from Hold to Buy. Oscar Health, Inspire Medical Systems, Autoliv, and Herbalife also caught upgrades as analysts adjust their outlooks.

Wednesday brought a flurry of optimism from Wall Street's analyst desks, with several companies getting fresh votes of confidence. When analysts flip their ratings, it's worth paying attention—especially when the price targets jump alongside them.

Leading the charge is Autodesk, Inc. (ADSK), the design software giant that just earned a promotion from Deutsche Bank analyst Bhavin Shah. He moved the stock from Hold to Buy and lifted his price target to $375 from $345. That's a meaningful bump considering Autodesk shares closed Tuesday at $294.43, suggesting Shah sees roughly 27% upside from here.

Healthcare got some love too. Piper Sandler analyst Jessica Tassan upgraded Oscar Health, Inc. (OSCR) from Neutral to Overweight and nearly doubled the price target—jumping from $13 to $25. The stock closed Tuesday at $16.73, so Tassan is clearly seeing something she likes in the health insurance company's trajectory.

Medical device maker Inspire Medical Systems, Inc. (INSP) also caught an upgrade from Truist Securities analyst Richard Newitter, who shifted from Hold to Buy and raised his target from $128 to $165. Inspire shares closed at $130.39 on Tuesday, meaning Newitter sees potential for roughly 26% gains ahead.

Meanwhile, Autoliv, Inc. (ALV)—the Swedish-American automotive safety company—got a boost from JP Morgan analyst Jose Asumendi, who moved the rating from Neutral to Overweight. The price target climbed from $109 to $140, with shares having closed Tuesday at $117.38.

Rounding out the list is Herbalife Ltd. (HLF), which Argus Research analyst John Staszak upgraded from Hold to Buy. Herbalife shares closed at $11.83 on Tuesday.

These rating changes represent shifting sentiment on Wall Street, where analysts are adjusting their models and expectations based on fresh data, company performance, and market conditions. Whether these upgrades prove prescient remains to be seen, but they certainly signal increased confidence from some of the Street's key voices.

Back to News

Autodesk Gets a Bullish Call: 5 Analyst Upgrades Making Waves

MarketDash Editorial Team
11 days ago
Wall Street analysts are shifting their stance on several notable companies, with Autodesk leading the pack as Deutsche Bank flips from Hold to Buy. Oscar Health, Inspire Medical Systems, Autoliv, and Herbalife also caught upgrades as analysts adjust their outlooks.

Wednesday brought a flurry of optimism from Wall Street's analyst desks, with several companies getting fresh votes of confidence. When analysts flip their ratings, it's worth paying attention—especially when the price targets jump alongside them.

Leading the charge is Autodesk, Inc. (ADSK), the design software giant that just earned a promotion from Deutsche Bank analyst Bhavin Shah. He moved the stock from Hold to Buy and lifted his price target to $375 from $345. That's a meaningful bump considering Autodesk shares closed Tuesday at $294.43, suggesting Shah sees roughly 27% upside from here.

Healthcare got some love too. Piper Sandler analyst Jessica Tassan upgraded Oscar Health, Inc. (OSCR) from Neutral to Overweight and nearly doubled the price target—jumping from $13 to $25. The stock closed Tuesday at $16.73, so Tassan is clearly seeing something she likes in the health insurance company's trajectory.

Medical device maker Inspire Medical Systems, Inc. (INSP) also caught an upgrade from Truist Securities analyst Richard Newitter, who shifted from Hold to Buy and raised his target from $128 to $165. Inspire shares closed at $130.39 on Tuesday, meaning Newitter sees potential for roughly 26% gains ahead.

Meanwhile, Autoliv, Inc. (ALV)—the Swedish-American automotive safety company—got a boost from JP Morgan analyst Jose Asumendi, who moved the rating from Neutral to Overweight. The price target climbed from $109 to $140, with shares having closed Tuesday at $117.38.

Rounding out the list is Herbalife Ltd. (HLF), which Argus Research analyst John Staszak upgraded from Hold to Buy. Herbalife shares closed at $11.83 on Tuesday.

These rating changes represent shifting sentiment on Wall Street, where analysts are adjusting their models and expectations based on fresh data, company performance, and market conditions. Whether these upgrades prove prescient remains to be seen, but they certainly signal increased confidence from some of the Street's key voices.